<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">EXCLI J</journal-id><journal-id journal-id-type="iso-abbrev">EXCLI J</journal-id><journal-id journal-id-type="publisher-id">EXCLI J</journal-id><journal-title-group><journal-title>EXCLI Journal</journal-title></journal-title-group><issn pub-type="epub">1611-2156</issn><publisher><publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31938028</article-id><article-id pub-id-type="pmc">6953533</article-id><article-id pub-id-type="publisher-id">2019-2071</article-id><article-id pub-id-type="doi">10.17179/excli2019-2071</article-id><article-id pub-id-type="publisher-id">Doc1097</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial Material</subject></subj-group></article-categories><title-group><article-title>Highlight report: Role of choline phospholipid metabolism in tumor progression</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Albrecht</surname><given-names>Wiebke</given-names></name><xref ref-type="corresp" rid="COR1">*</xref><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Leibniz Research Centre for Working Environment and Human Factors</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed: Wiebke Albrecht, Leibniz Research Centre for Working Environment and Human Factors, Ardeystr. 67, 44139 Dortmund, Germany, E-mail: <email>albrecht@ifado.de</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>18</volume><fpage>1097</fpage><lpage>1098</lpage><history><date date-type="received"><day>16</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>17</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Albrecht</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>) You are free to copy, distribute and transmit the work, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="https://www.excli.de/vol18/Albrecht_19122019_proof.pdf">This article is available from https://www.excli.de/vol18/Albrecht_19122019_proof.pdf</self-uri></article-meta></front><body><sec><title>&#x0206f;&#x0206f;&#x0206f;&#x0206f;</title><p>Recently, Sonkar and colleagues published a comprehensive review about the glycerophosphocholine (GPC) pathway and its role in cancer biology (Sonkar et al., 2019[<xref rid="R24" ref-type="bibr">24</xref>]). The authors address the enzymes of the GPC breakdown pathway; the oncogenic signaling pathways and transcription factors that regulate the GPC pathway; the interactions of the GPC pathway with other biochemical pathways such as glycolysis and triglyceride metabolism, and finally focus on non-invasive magnetic resonance spectroscopy techniques for detection of GPC in tumor tissue. Activation of choline metabolism is a critical step of cancer development and may lead to increased levels of phosphocholine, GPC and total choline-containing compounds (Hanahan and Weinberg, 2011[<xref rid="R14" ref-type="bibr">14</xref>]; Griffiths et al., 1981[<xref rid="R13" ref-type="bibr">13</xref>]; Daly et al., 1987[<xref rid="R8" ref-type="bibr">8</xref>]; Aboagye and Bhujwalla, 1999[<xref rid="R1" ref-type="bibr">1</xref>]; Gillies et al., 2002[<xref rid="R10" ref-type="bibr">10</xref>]). These changes can be detected by magnetic resonance spectroscopy (Baek et al., 2008[<xref rid="R3" ref-type="bibr">3</xref>]; Bolan et al., 2003[<xref rid="R4" ref-type="bibr">4</xref>]; He et al., 2003-2004[<xref rid="R15" ref-type="bibr">15</xref>]; Al-Saffar et al., 2017[<xref rid="R2" ref-type="bibr">2</xref>]; Glunde et al., 2011[<xref rid="R11" ref-type="bibr">11</xref>]). The glycerophosphodiesterase GPCPD1 is a key enzyme in choline metabolism that cleaves GPC to glycerol-3-phosphate (G3P) and choline (Stewart et al., 2012[<xref rid="R25" ref-type="bibr">25</xref>]). This activity mediates integrin expression, tumor cell adhesion, spreading and migration (Lesjak et al., 2014[<xref rid="R17" ref-type="bibr">17</xref>]; Marchan et al., 2012[<xref rid="R19" ref-type="bibr">19</xref>]). Recently, glycerol-3-phosphate acyltransferase1, which further processes G3P to generate lysophosphatidic acid (LPA) has been shown to promote tumor cell migration and is associated with poor survival in ovarian cancer (Marchan et al., 2017[<xref rid="R19" ref-type="bibr">19</xref>]). </p><p>Besides phospholipid metabolism and metastasis tumor progression involves numerous further processes, such as proliferation (Schmidt et al., 2008[<xref rid="R20" ref-type="bibr">20</xref>]; Hellwig et al., 2016[<xref rid="R16" ref-type="bibr">16</xref>]; Siggelkow et al., 2012[<xref rid="R23" ref-type="bibr">23</xref>]), immune cell infiltration (Edlund et al., 2019[<xref rid="R9" ref-type="bibr">9</xref>]; Schmidt et al., 2012[<xref rid="R21" ref-type="bibr">21</xref>], 2018[<xref rid="R22" ref-type="bibr">22</xref>]; Godoy et al., 2014[<xref rid="R12" ref-type="bibr">12</xref>]), oxidative stress response (Cadenas et al., 2019[<xref rid="R6" ref-type="bibr">6</xref>]; 2014[<xref rid="R5" ref-type="bibr">5</xref>]; 2012[<xref rid="R7" ref-type="bibr">7</xref>]). Studies in future will have to show if targeting members of the glycerophosphocholine pathway will delay tumor progression. The present review of Sonkar et al. gives a comprehensive summary of the state-of-the-art in this field and is of high value to anyone interested in how choline-phospholipid-metabolism is linked to tumor development. </p></sec><sec><title>Conflict of interest</title><p>The author declares no conflict of interest.</p></sec></body><back><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal">
<person-group><name><surname>Aboagye</surname><given-names>EO</given-names></name><name><surname>Bhujwalla</surname><given-names>ZM</given-names></name></person-group>
<article-title>Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells</article-title>
<source>Cancer Res</source>
<year>1999</year>
<volume>59</volume>
<fpage>80</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">9892190</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal">
<person-group><name><surname>Al-Saffar</surname><given-names>NMS</given-names></name><name><surname>Agliano</surname><given-names>A</given-names></name><name><surname>Marshall</surname><given-names>LV</given-names></name><name><surname>Jackson</surname><given-names>LE</given-names></name><name><surname>Balarajah</surname><given-names>G</given-names></name><name><surname>Sidhu</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells</article-title>
<source>PLoS One</source>
<year>2017</year>
<volume>12</volume>
<fpage>e0180263</fpage>
<pub-id pub-id-type="pmid">28704425</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal">
<person-group><name><surname>Baek</surname><given-names>HM</given-names></name><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Nalcioglu</surname><given-names>O</given-names></name><name><surname>Su</surname><given-names>MY</given-names></name></person-group>
<article-title>Choline as a biomarker for cell proliferation: do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers?</article-title>
<source>Int J Cancer</source>
<year>2008</year>
<volume>123</volume>
<fpage>1219</fpage>
<lpage>1221</lpage>
<pub-id pub-id-type="pmid">18546272</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal">
<person-group><name><surname>Bolan</surname><given-names>PJ</given-names></name><name><surname>Meisamy</surname><given-names>S</given-names></name><name><surname>Baker</surname><given-names>EH</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Emory</surname><given-names>T</given-names></name><name><surname>Nelson</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>In vivo quantification of choline compounds in the breast with 1H MR spectroscopy</article-title>
<source>Magn Reson Med</source>
<year>2003</year>
<volume>50</volume>
<fpage>1134</fpage>
<lpage>1143</lpage>
<pub-id pub-id-type="pmid">14648561</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>van de Sandt</surname><given-names>L</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Lohr</surname><given-names>M</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Loss of circadian clock gene expression is associated with tumor progression in breast cancer</article-title>
<source>Cell Cycle</source>
<year>2014</year>
<volume>13</volume>
<fpage>3282</fpage>
<lpage>3291</lpage>
<pub-id pub-id-type="pmid">25485508</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Vosbeck</surname><given-names>S</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Grgas</surname><given-names>K</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer</article-title>
<source>Int J Cancer</source>
<year>2019</year>
<volume>145</volume>
<fpage>901</fpage>
<lpage>915</lpage>
<pub-id pub-id-type="pmid">30653260</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Vosbeck</surname><given-names>S</given-names></name><name><surname>Hein</surname><given-names>EM</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Langer</surname><given-names>A</given-names></name><name><surname>Hayen</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Glycerophospholipid profile in oncogene-induced senescence</article-title>
<source>Biochim Biophys Acta</source>
<year>2012</year>
<volume>1821</volume>
<fpage>1256</fpage>
<lpage>1268</lpage>
<pub-id pub-id-type="pmid">22178194</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal">
<person-group><name><surname>Daly</surname><given-names>PF</given-names></name><name><surname>Lyon</surname><given-names>RC</given-names></name><name><surname>Faustino</surname><given-names>PJ</given-names></name><name><surname>Cohen</surname><given-names>JS</given-names></name></person-group>
<article-title>Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy</article-title>
<source>J Biol Chem</source>
<year>1987</year>
<volume>262</volume>
<fpage>14875</fpage>
<lpage>14878</lpage>
<pub-id pub-id-type="pmid">3667610</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal">
<person-group><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Mattsson</surname><given-names>JSM</given-names></name><name><surname>Djureinovic</surname><given-names>D</given-names></name><name><surname>Lindskog</surname><given-names>C</given-names></name><name><surname>Brunnstr&#x000f6;m</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Prognostic impact of tumor cell programmed death ligand 1 expression and immune cell infiltration in NSCLC</article-title>
<source>J Thorac Oncol</source>
<year>2019</year>
<volume>14</volume>
<fpage>628</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="pmid">30639618</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal">
<person-group><name><surname>Gillies</surname><given-names>RJ</given-names></name><name><surname>Raghunand</surname><given-names>N</given-names></name><name><surname>Karczmar</surname><given-names>GS</given-names></name><name><surname>Bhujwalla</surname><given-names>ZM</given-names></name></person-group>
<article-title>MRI of the tumor microenvironment</article-title>
<source>J Magn Reson Imaging</source>
<year>2002</year>
<volume>16</volume>
<fpage>430</fpage>
<lpage>450</lpage>
<pub-id pub-id-type="pmid">12353258</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal">
<person-group><name><surname>Glunde</surname><given-names>K</given-names></name><name><surname>Bhujwalla</surname><given-names>ZM</given-names></name><name><surname>Ronen</surname><given-names>SM</given-names></name></person-group>
<article-title>Choline metabolism in malignant transformation</article-title>
<source>Nat Rev Cancer</source>
<year>2011</year>
<volume>11</volume>
<fpage>835</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="pmid">22089420</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal">
<person-group><name><surname>Godoy</surname><given-names>P</given-names></name><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>J</given-names></name><name><surname>Reif</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response</article-title>
<source>Breast Cancer</source>
<year>2014</year>
<volume>21</volume>
<fpage>491</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="pmid">23001506</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal">
<person-group><name><surname>Griffiths</surname><given-names>JR</given-names></name><name><surname>Stevens</surname><given-names>AN</given-names></name><name><surname>Iles</surname><given-names>RA</given-names></name><name><surname>Gordon</surname><given-names>RE</given-names></name><name><surname>Shaw</surname><given-names>D</given-names></name></person-group>
<article-title>31P-NMR investigation of solid tumours in the living rat</article-title>
<source>Biosci Rep</source>
<year>1981</year>
<volume>1</volume>
<fpage>319</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">7295895</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal">
<person-group><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group>
<article-title>Hallmarks of cancer: the next generation</article-title>
<source>Cell</source>
<year>2011</year>
<volume>144</volume>
<fpage>646</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal">
<person-group><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>RZ</given-names></name><name><surname>Shkarin</surname><given-names>P</given-names></name><name><surname>Pizzorno</surname><given-names>G</given-names></name><name><surname>Lee-French</surname><given-names>CH</given-names></name><name><surname>Rothman</surname><given-names>DL</given-names></name><etal/></person-group>
<article-title>Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment</article-title>
<source>Dis Markers</source>
<year>2003-2004</year>
<volume>19</volume>
<fpage>69</fpage>
<lpage>94</lpage>
</element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal">
<person-group><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Heimes</surname><given-names>AS</given-names></name><etal/></person-group>
<article-title>Epsin family member 3 and ribosome-related genes are associated with late metastasis in estrogen receptor-positive breast cancer and long-term survival in non-small cell lung cancer using a genome-wide identification and validation strategy</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<fpage>e0167585</fpage>
<pub-id pub-id-type="pmid">27926932</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal">
<person-group><name><surname>Lesjak</surname><given-names>MS</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>JD</given-names></name><name><surname>Rempel</surname><given-names>E</given-names></name><name><surname>Rahnenf&#x000fc;hrer</surname><given-names>J</given-names></name><name><surname>Hengstler</surname><given-names>JG</given-names></name></person-group>
<article-title>EDI3 links choline metabolism to integrin expression, cell adhesion and spreading</article-title>
<source>Cell Adh Migr</source>
<year>2014</year>
<volume>8</volume>
<fpage>499</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="pmid">25482527</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal">
<person-group><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>B&#x000fc;ttner</surname><given-names>B</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Glaeser</surname><given-names>I</given-names></name><name><surname>Blaszkewicz</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma</article-title>
<source>Cancer Res</source>
<year>2017</year>
<volume>77</volume>
<fpage>4589</fpage>
<lpage>4601</lpage>
<pub-id pub-id-type="pmid">28652252</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal">
<person-group><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Lesjak</surname><given-names>MS</given-names></name><name><surname>Stewart</surname><given-names>JD</given-names></name><name><surname>Winter</surname><given-names>R</given-names></name><name><surname>Seeliger</surname><given-names>J</given-names></name><name><surname>Hengstler</surname><given-names>JG</given-names></name></person-group>
<article-title>Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities</article-title>
<source>Cell Cycle</source>
<year>2012</year>
<volume>11</volume>
<fpage>4499</fpage>
<lpage>4506</lpage>
<pub-id pub-id-type="pmid">23114620</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal">
<person-group><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>D</given-names></name><name><surname>von T&#x000f6;rne</surname><given-names>C</given-names></name><name><surname>Steiner</surname><given-names>E</given-names></name><name><surname>Puhl</surname><given-names>A</given-names></name><name><surname>Pilch</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>The humoral immune system has a key prognostic impact in node-negative breast cancer</article-title>
<source>Cancer Res</source>
<year>2008</year>
<volume>68</volume>
<fpage>5405</fpage>
<lpage>5413</lpage>
<pub-id pub-id-type="pmid">18593943</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal">
<person-group><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Hammad</surname><given-names>S</given-names></name><name><surname>Othman</surname><given-names>A</given-names></name><name><surname>Lohr</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin &#x003ba; C as a compatible prognostic marker in human solid tumors</article-title>
<source>Clin Cancer Res</source>
<year>2012</year>
<volume>18</volume>
<fpage>2695</fpage>
<lpage>2703</lpage>
<pub-id pub-id-type="pmid">22351685</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal">
<person-group><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Weyer-Elberich</surname><given-names>V</given-names></name><name><surname>Hengstler</surname><given-names>JG</given-names></name><name><surname>Heimes</surname><given-names>AS</given-names></name><name><surname>Almstedt</surname><given-names>K</given-names></name><name><surname>Gerhold-Ay</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population</article-title>
<source>Breast Cancer Res</source>
<year>2018</year>
<volume>20</volume>
<fpage>15</fpage>
<pub-id pub-id-type="pmid">29482642</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal">
<person-group><name><surname>Siggelkow</surname><given-names>W</given-names></name><name><surname>Boehm</surname><given-names>D</given-names></name><name><surname>Gebhard</surname><given-names>S</given-names></name><name><surname>Battista</surname><given-names>M</given-names></name><name><surname>Sicking</surname><given-names>I</given-names></name><name><surname>Lebrecht</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients</article-title>
<source>BMC Cancer</source>
<year>2012</year>
<volume>12</volume>
<fpage>562</fpage>
<pub-id pub-id-type="pmid">23186136</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal">
<person-group><name><surname>Sonkar</surname><given-names>K</given-names></name><name><surname>Ayyappan</surname><given-names>V</given-names></name><name><surname>Tressler</surname><given-names>CM</given-names></name><name><surname>Adelaja</surname><given-names>O</given-names></name><name><surname>Cai</surname><given-names>R</given-names></name><name><surname>Cheng</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer</article-title>
<source>NMR Biomed</source>
<year>2019</year>
<volume>32</volume>
<fpage>e4112</fpage>
<pub-id pub-id-type="pmid">31184789</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal">
<person-group><name><surname>Stewart</surname><given-names>JD</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Lesjak</surname><given-names>MS</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Hergenroeder</surname><given-names>R</given-names></name><name><surname>Ellis</surname><given-names>JK</given-names></name><etal/></person-group>
<article-title>Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2012</year>
<volume>109</volume>
<fpage>8155</fpage>
<lpage>8160</lpage>
<pub-id pub-id-type="pmid">22570503</pub-id></element-citation></ref></ref-list></back></article>